EMERGENCY
NUMBERS
After Hours
13 74 25
Appointments
Contact
Hours
Doctors
Fees
Feedback
About
Home
Immunisation
Local Pharmacies
Resources


AVOCA STREET MEDICAL CENTRE
 
130 Avoca Street Randwick NSW 2031
Tel: 02 9399 3335 - Fax: 02 9399 9778

avocastreet.com - asmc.net.au - randwickhealth.com - randwickgp.com - familydoctor.sydney

SURGERY HOURS

MON - THU8 AM - 6 PM
FRI8 AM - 3 PM
SAT9 AM - 12 PM
SUN & PUBLIC HOLIDAYSCLOSED

Sorry. We are CLOSED

Reopening 8 AM Thursday 20/12/2018

For services after hours please call 13 74 25

Business Hours During Holiday Season

24/12/20188AM 3PM
25/12/2018CHRISTMASCLOSED
26/12/2018BOXING DAYCLOSED
27/12/20188AM 3PM
28/12/20188AM 12PM
29/12/20189AM 12PM
30/12/2018SUNDAYCLOSED
31/12/20188AM 3PM
01/01/2019NEW YEAR'S DAYCLOSED
02/01/20198AM 3PM
03/01/20198AM 3PM
04/01/20198AM 12PM
05/01/20199AM 12PM

NOTICES

Dr Angela will be away
20/01/2019 - 28/01/2019
Dr Kien will be away
04/02/2019 - 10/02/2019
Dr Mandy will be away
24/12/2018 - 09/01/2019

GENERAL PRACTITIONERS

Dr. Angela Georgopoulos

Dr. Kien Cao-Xuan

Dr. Mandy Chuang

Dr. Priscilla Wong

 

General Information
 

Bexsero - Meningococcus B Vaccine
Meningococcus is a bacteria that is like the shark attack of the infectious world. It strikes with very little warning, death can occur and there is risk of losing a limb or two. Penicillin can fix it, but detecting it early is impossible. There are a 13 serotypes designated letters such as A, B, and C.

Type B causes 80% of disease in Australia is responsible for nearly all the deaths. Type C has had an effective vaccine since 2003. But type B has a large number of strains which has made vaccine development difficult until now.



Bexsero is the name given to the new vaccine and it covers around 80% of Meningococcus B strains in Australia and other parts of the World. It is not yet on the standard schedule but is recommended and can be obtained privately.

Based on their higher disease risk, 4CMenB is recommended for these groups:

  • Infants and young children, particularly those aged <24 months
  • Adolescents aged 15 to 19 years
  • Children and adults with medical conditions that place them at a high risk of IMD, such as functional or anatomical asplenia or complement component disorders
  • Laboratory personnel who frequently handle Neisseria meningitidis.

For infants aged <6 months, 3 primary doses of 4CMenB plus a booster at age 12 months are recommended. Fewer doses are required for older age groups.



4CMenB may be given to infants at the same time as other infant vaccines that are given under the NIP, but must be given at a separate injection site. The 1st dose of 4CMenB may be administered as early as 6 weeks of age to align with the NIP infant schedule.

More from www.immunise.health.gov.au

The increasing demand for Bexsero across the world means that supply of the vaccine to Australia is constrained and will be unavailable until early 2017. [au.gsk.com]

The information in the above were collected from the internet,
either from government websites or from reasonably reliable health information sources.
They are for general information only and should not replace the need of seeking medical care during illnesses.


| | 🡹 | | contact | | hours | | doctors | | about